XTX Topco’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

XTX Topco’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-104,437	Closed	-$278K	–	2644
2024 Q1	$278K	Buy	104,437 +42,971	+70%	+$106K	0.04%	919
2023 Q4	$146K	Buy	61,466 +12,603	+26%	+$22.3K	0.03%	1050
2023 Q3	$68.4K	Sell	48,863 -23,437	-32%	-$56.3K	0.01%	1235
2023 Q2	$219K	Buy	+72,300	New	+$279K	0.04%	946
2023 Q1	–	Sell	-38,790	Closed	-$237K	–	1749
2022 Q4	$237K	Buy	+38,790	New	+$316K	0.05%	739

XTX Topco's KNTE Position: Q2 2024 in Review

XTX Topco sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 104,437 shares — an estimated $278K sold.

XTX Topco first reported a position in KNTE in Q4 2022 and held it in 5 quarters. The position peaked at $278K in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

XTX Topco reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
XTX Topco sold 104,437 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $278K.
XTX Topco first reported a position in Kinnate Biopharma Inc. Common Stock in Q4 2022 and held it in 5 quarters.
XTX Topco's Kinnate Biopharma Inc. Common Stock position peaked at $278K in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.